scholarly journals A rare case of intraductal papilloma with atypical ductal hyperplasia in a male breast: A pathological diagnosis

2020 ◽  
Vol 27 (3) ◽  
pp. 216
Author(s):  
JyotsnaNaresh Bharti ◽  
Sushma Bharti ◽  
JeewanRam Vishnoi ◽  
ArshaB Soudamini
2018 ◽  
Vol 13 (3) ◽  
pp. 602-605 ◽  
Author(s):  
Gaurav Anand ◽  
Nabil Al-Khalisi ◽  
Dauod Arif ◽  
Soheila Hamidpour ◽  
Tiffany Lewis

2005 ◽  
Vol 47 (1) ◽  
pp. 111-112 ◽  
Author(s):  
Z Z R Hamady ◽  
P J Carder ◽  
T G Brennan

Diagnostics ◽  
2021 ◽  
Vol 11 (12) ◽  
pp. 2199
Author(s):  
Daniele Ugo Tari ◽  
Luigi Morelli ◽  
Antonella Guida ◽  
Fabio Pinto

Ductal carcinoma in situ (DCIS) of male breast is a rare lesion, often associated with invasive carcinoma. When the in situ component is present in pure form, histological grade is usually low or intermediate. Imaging is difficult as gynaecomastia is often present and can mask underlying findings. We report a rare case of pure high-grade DCIS in a young male patient, with associated intraductal papilloma and atypical ductal hyperplasia. Digital breast tomosynthesis (DBT) showed an area of architectural distortion at the union of outer quadrants of the left breast without gynaecomastia. Triple assessment suggested performing a nipple-sparing mastectomy, which revealed the presence of a focal area of high-grade DCIS of 2 mm. DCIS, even of high grade, is difficult to detect with mammography and even more rare, especially when associated with other proliferative lesions. DBT with 2D synthetic reconstruction is useful as the imaging step of a triple assessment and it should be performed in both symptomatic and asymptomatic high-risk men to differentiate between malignant and benign lesions. We propose a diagnostic model to early detect breast cancer in men, optimizing resources according to efficiency, effectiveness and economy, and look forward to radiomics as a powerful tool to help radiologists.


2019 ◽  
Vol 26 (7) ◽  
pp. 893-899 ◽  
Author(s):  
Kristin E. Williams ◽  
Amanda Amin ◽  
Jacqueline Hill ◽  
Carissa Walter ◽  
Marc Inciardi ◽  
...  

2018 ◽  
Vol 6 ◽  
pp. 205031211881154 ◽  
Author(s):  
Ichiro Maeda ◽  
Shinya Tajima ◽  
Yoshihide Kanemaki ◽  
Koichiro Tsugawa ◽  
Masayuki Takagi

Objectives: The aim of this study was to use immunohistochemistry to differentiate solid papillary carcinoma in situ from intraductal papilloma with usual ductal hyperplasia (IPUDH). Three types of high-molecular-weight cytokeratins (CKs) – CK5/6, CK14, and CK34betaE12 – were targeted. Methods: We studied 17 patients with solid papillary carcinoma in situ and 18 patients with IPUDH diagnosed by at least two pathologists. Immunohistochemical analyses used antibodies to CK5/6, CK14, and CK34betaE12 to make the differential diagnosis of solid papillary carcinoma in situ versus IPUDH. Immunohistochemical staining was scored as 0–5 using Allred score. Results: Immunohistochemistry with CK5/6 and CK14 antibodies produced scores of 0–3 in all patients with solid papillary carcinoma in situ and 2–5 in all patients with IPUDH. Immunohistochemical staining with CK34betaE12 antibody produced scores of 1–3 in all patients with solid papillary carcinoma and 3–5 in all patients with IPUDH. In tissues from patients with IPUDH, significantly more cells were stained with CK34betaE12 than CK5/6 ( p < 0.05) or CK14 ( p < 0.05). Conclusion: The immunoreactivity of CK5/6, CK14, and CK34betaE12 antibodies was useful to differentiate solid papillary carcinoma in situ from IPUDH. CK34betaE12 is especially useful for distinguishing solid papillary carcinoma from IPUDH.


Sign in / Sign up

Export Citation Format

Share Document